ナミキ商事株式会社 医薬品及び創薬化学品の専門商社

医薬品及び創薬化学品の専門商社

検索検索

バイオ製品Bio Products

タンパク質、抗体、アッセイキット

タンパク質カタログ

輸入に関する法規制チェックは、御見積のご依頼をいただいた際に行います。
法規制によっては、定価として記載の価格に追加の費用が発生する場合や供給出来ない場合がございますので、あらかじめご了承ください。

サプライヤー
TargteMol
カタログNo.
TMPY-02096
製品名称
TACI Protein, Human, Recombinant (His)
タンパク質名
TACI
Species
Human
HOST
HEK293 Cells
100μg: -
お問い合わせ

Overview

Synonyms RYZN, IGAD2, CVID, TACI, TNFRSF14B, CVID2, tumor necrosis factor receptor superfamily, member 13B, CD267
Characteristics Activity testing is in progress. It is theoretically active, but we cannot guarantee it. If you require protein activity, we recommend choosing the eukaryotic expression version first.
Endotoxin Level < 1.0 EU/μg of the protein as determined by the LAL method.
Purity 97.80%
Description TACI Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells with His tag. The predicted molecular weight is 14.8 kDa and the accession number is O14836-2.
Reference Mohammadi J,et al.(2009) Novel mutations in TACI (TNFRSF13B) causing common variable immunodeficiency. J Clin Immunol. 29(6): 777-85.,Salzer U,et al.(2009) Relevance of biallelic versus monoallelic TNFRSF13B mutations in distinguishing disease-causing from risk-increasing TNFRSF13B variants in antibody deficiency syndromes. Blood. 113(9): 1967-76.,Salzer U,et al.(2005) Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat Genet. 37(8): 820-8.
URL https://www.targetmol.com/recombinant-protein/taci_protein_human_recombinant_ecd_his_tag_

お問い合わせリスト(-)

お問い合わせフォーム